Skip to main content

TGen Begins $1.3M ALS Gene Screening With Funds From MDA

NEW YORK, March 20 (GenomeWeb News) - Translational Genomics has begun collecting 1,000 patient samples to undergo screening for variants causing ALS, or Lou Gehrig's Disease, the company said today.

 

The project is being funded with a donation of $650,000 from Augie's Quest, administered by the Muscular Dystrophy Association, and with a matching investment of $650,000 from TGen, said project director Dietrich Stephen.

 

Stephen said that the screening will be done on an Affymetrix 500K platform.

 

The samples are being collected primarily from the University of Pittsburgh, California Pacific Medical Center, Methodist Neorological Institute, and the Western ALS Group.

 

Stephen said the project will be completed by the end of 2006.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.